These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7845553)

  • 21. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J; Zushida K; Ohsawa M; Nagase H
    Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats.
    Matsuzaki S; Ikeda H; Akiyama G; Sato M; Moribe S; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuropharmacology; 2004 Jun; 46(8):1089-96. PubMed ID: 15111015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
    Negri L; Lattanzi R; Melchiorri P
    Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two mu opioid receptor subtypes that modulate antinociception and catalepsy in the rat.
    Negri L; Erspamer GF; Severini C; Potenza RL; Melchiorri P; Erspamer V
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):7203-7. PubMed ID: 1353890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL; Wang H; Nakashima N; Basbaum AI
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats.
    Ragnauth A; Moroz M; Bodnar RJ
    Brain Res; 2000 Sep; 876(1-2):76-87. PubMed ID: 10973595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
    Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
    Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
    Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
    J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
    Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
    Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
    Heyman JS; Williams CL; Burks TF; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens.
    Longoni R; Spina L; Mulas A; Carboni E; Garau L; Melchiorri P; Di Chiara G
    J Neurosci; 1991 Jun; 11(6):1565-76. PubMed ID: 1646295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dermorphin analog Tyr-D-Arg2-Phe-sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors?
    Paakkari P; Paakkari I; Vonhof S; Feuerstein G; Sirén AL
    J Pharmacol Exp Ther; 1993 Aug; 266(2):544-50. PubMed ID: 8394909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats.
    Honkanen A; Vilamo L; Wegelius K; Sarviharju M; Hyytiä P; Korpi ER
    Eur J Pharmacol; 1996 May; 304(1-3):7-13. PubMed ID: 8813578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
    Noble F; Smadja C; Roques BP
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delta, mu and kappa opioid receptor agonists inhibit dopamine overflow in rat neostriatal slices.
    Schlösser B; Kudernatsch MB; Sutor B; ten Bruggencate G
    Neurosci Lett; 1995 May; 191(1-2):126-30. PubMed ID: 7659278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of peripheral opioid receptor subtypes in the modulation of gastric acid secretion and plasma gastrin in dogs.
    Intorre L; Mengozzi G; Vanni E; Grassi F; Soldani G
    Eur J Pharmacol; 1993 Oct; 243(3):265-72. PubMed ID: 8276079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.